Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.

Ehlers L, Askling J, Bijlsma HW, Cid MC, Cutolo M, Dasgupta B, Dejaco C, Dixon WG, Feltelius N, Finckh A, Gilbert K, Mackie SL, Mahr A, Matteson EL, Neill L, Salvarani C, Schmidt WA, Strangfeld A, van Vollenhoven RF, Buttgereit F.

Ann Rheum Dis. 2019 Mar 21. pii: annrheumdis-2018-214755. doi: 10.1136/annrheumdis-2018-214755. [Epub ahead of print]

PMID:
30898837
2.

Update on Outcome Measure Development in Large-Vessel Vasculitis: Report from OMERACT 2018.

Aydin SZ, Robson JC, Sreih AG, Hill C, Alibaz-Oner F, Mackie S, Beard S, Hatemi G, Kermani TA, Mahr A, Meara A, Milman N, Shea B, Tómasson G, Tugwell P, Direskeneli H, Merkel PA.

J Rheumatol. 2019 Mar 15. pii: jrheum.181072. doi: 10.3899/jrheum.181072. [Epub ahead of print]

PMID:
30877212
3.

Nomenklatur der kutanen Vaskulitiden - deutschsprachige Definitionen des Dermatologischen Anhanges zur Chapel Hill Consensus Conference.

Sunderkötter C, Lamprecht P, Mahr A, Metze D, Zelger B.

J Dtsch Dermatol Ges. 2018 Dec;16(12):1425-1433. doi: 10.1111/ddg.13703_g. Review. No abstract available.

PMID:
30537318
4.

Nomenclature of cutaneous vasculitides - German translation of the dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter C, Lamprecht P, Mahr A, Metze D, Zelger B.

J Dtsch Dermatol Ges. 2018 Dec;16(12):1425-1432. doi: 10.1111/ddg.13703. Review.

PMID:
30537317
5.

Vaccination and Risk of Childhood IgA Vasculitis.

Piram M, Gonzalez Chiappe S, Madhi F, Ulinski T, Mahr A.

Pediatrics. 2018 Nov;142(5). pii: e20180841. doi: 10.1542/peds.2018-0841.

PMID:
30377240
6.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
7.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2019 Feb;48(4):752-762. doi: 10.1016/j.semarthrit.2018.05.008. Epub 2018 May 19.

PMID:
29954598
8.

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.

Sreih AG, Ezzedine R, Leng L, Fan J, Yao J, Reid D, Piecychna M, Carette S, Cuthbertson D, Dellaripa P, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Mahr A, McAlear CA, Maksimowicz-Mckinnon K, Monach PA, Seo P, Specks U, St Clair EW, Stone JH, Ytterberg SR, Edberg J, Merkel PA, Bucala R.

Arthritis Rheumatol. 2018 Dec;70(12):2077-2086. doi: 10.1002/art.40655. Epub 2018 Oct 22.

PMID:
29953750
9.

The European Vasculitis Society 2016 Meeting Report.

Bajema IM, Bruijn JA, Casian A, Cid MC, Csernok E, van Daalen E, Harper L, Hauser T, Little MA, Luqmani RA, Mahr A, Ponte C, Salama A, Segelmark M, Suzuki K, Sznajd J, Teng YKO, Vaglio A, Westman K, Jayne D.

Kidney Int Rep. 2017 Sep 21;2(6):1018-1031. doi: 10.1016/j.ekir.2017.09.008. eCollection 2017 Nov.

10.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
11.

Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980-2011).

Aouba A, Gonzalez Chiappe S, Eb M, Delmas C, de Boysson H, Bienvenu B, Rey G, Mahr A.

Rheumatology (Oxford). 2018 Jun 1;57(6):1047-1055. doi: 10.1093/rheumatology/key028.

PMID:
29554340
12.

Blue toe syndrome in cutaneous polyarteritis nodosa.

Tounkara TM, Jachiet M, Frumholtz L, Battistella M, Cisse M, Mahr A, Bagot M, Cordoliani F, Bouaziz JD.

Rheumatology (Oxford). 2018 Mar 9. doi: 10.1093/rheumatology/key061. [Epub ahead of print] No abstract available.

PMID:
29534226
13.

Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection.

Fritsche J, Rakitsch B, Hoffgaard F, Römer M, Schuster H, Kowalewski DJ, Priemer M, Stos-Zweifel V, Hörzer H, Satelli A, Sonntag A, Goldfinger V, Song C, Mahr A, Ott M, Schoor O, Weinschenk T.

Proteomics. 2018 Jun;18(12):e1700284. doi: 10.1002/pmic.201700284. Epub 2018 Apr 10.

14.

Does a "stoplight!" improve processing a stoplight? Cross-modal influences of time-compressed spoken denotations on automotive icon classification.

Mahr A, Wentura D.

J Exp Psychol Appl. 2018 Mar;24(1):92-107. doi: 10.1037/xap0000158. Epub 2018 Feb 1.

PMID:
29389160
15.

Clinical and microbiological characteristics of the infections in patients treated with rituximab for autoimmune and/or malignant hematological disorders.

Tudesq JJ, Cartron G, Rivière S, Morquin D, Iordache L, Mahr A, Pourcher V, Klouche K, Cerutti D, Le Quellec A, Guilpain P.

Autoimmun Rev. 2018 Feb;17(2):115-124. doi: 10.1016/j.autrev.2017.11.015. Epub 2017 Nov 24. Review.

PMID:
29180125
16.

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC.

Arthritis Rheumatol. 2018 Feb;70(2):171-184. doi: 10.1002/art.40375. Review.

17.

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts.

Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T, Hellmich B, Holle J, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel P, Mills J, Mooney J, Segelmark M, Tesar V, Westman KWA, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

RMD Open. 2017 Jun 15;3(1):e000449. doi: 10.1136/rmdopen-2017-000449. eCollection 2017.

18.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

19.

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Sreih AG, Alibaz-Oner F, Kermani TA, Aydin SZ, Cronholm PF, Davis T, Easley E, Gul A, Mahr A, McAlear CA, Milman N, Robson JC, Tomasson G, Direskeneli H, Merkel PA.

J Rheumatol. 2017 Dec;44(12):1933-1937. doi: 10.3899/jrheum.161467. Epub 2017 Sep 1.

20.

Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.

Le Pendu C, Meignin V, Gonzalez-Chiappe S, Hij A, Galateau-Sallé F, Mahr A.

J Rheumatol. 2017 Jul;44(7):1039-1043. doi: 10.3899/jrheum.170061. Epub 2017 May 1.

PMID:
28461644
21.

[Epidemiology and natural history of giant cell arteritis].

Mahr A, Aouba A, Richebé P, Gonzalez-Chiappe S.

Rev Med Interne. 2017 Oct;38(10):663-669. doi: 10.1016/j.revmed.2017.03.007. Epub 2017 Apr 28. Review. French.

PMID:
28457683
22.

Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study.

Piram M, Maldini C, Biscardi S, De Suremain N, Orzechowski C, Georget E, Regnard D, Koné-Paut I, Mahr A.

Rheumatology (Oxford). 2017 Aug 1;56(8):1358-1366. doi: 10.1093/rheumatology/kex158.

PMID:
28444335
23.

Reply to: Behçet's disease: an MHC-I-opathy?

McGonagle D, Aydin SZ, Gül A, Mahr A, Direskeneli H.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):6. Epub 2017 Apr 14. No abstract available.

24.

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, Gurcan M, Davis T, Gul A, Yazici Y, Zottenberg K, Esatoglu SN, Erer B, Kamali S, Yazici H, Cronholm PF, Merkel PA.

J Rheumatol. 2017 Nov;44(11):1750-1753. doi: 10.3899/jrheum.161352. Epub 2017 Apr 1.

PMID:
28365574
25.

Exploring the variability in Behçet's disease prevalence: a meta-analytical approach.

Maldini C, Druce K, Basu N, LaValley MP, Mahr A.

Rheumatology (Oxford). 2018 Jan 1;57(1):185-195. doi: 10.1093/rheumatology/kew486.

PMID:
28339670
26.

Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era.

Iordache L, Bengoufa D, Taulera O, Rami A, Lascoux-Combe C, Day N, Parrinello M, Sellier PO, Molina JM, Mahr A.

Medicine (Baltimore). 2017 Mar;96(10):e6230. doi: 10.1097/MD.0000000000006230.

27.

Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.

Mahr A, Golmard C, Pham E, Iordache L, Deville L, Faure P.

Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):731-741. doi: 10.1002/pds.4169. Epub 2017 Feb 7. Review.

PMID:
28176407
28.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O'Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. Epub 2016 Dec 29.

29.

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 May;69(5):1054-1066. doi: 10.1002/art.40034. Epub 2017 Apr 6.

30.

Dietary and Nondietary Triggers of Oral Ulcer Recurrences in Behçet's Disease.

Volle G, Fraison JB, Gobert D, Goulenok T, Dhote R, Fain O, Gonzalez-Chiappe S, Lhote F, Papo T, Thuillier A, Rivière S, Mahr A.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1429-1436. doi: 10.1002/acr.23155.

31.

Reply to: "The relationship between lymphocytic thrombophilic arteritis and cutaneous polyarteritis nodosa".

Battistella M, Mahr A, Bagot M, Bouaziz JD.

J Am Acad Dermatol. 2016 Dec;75(6):e245-e246. doi: 10.1016/j.jaad.2016.07.005. No abstract available.

PMID:
27846978
32.

[Adult Langerhans cell histiocytosis].

de Menthon M, Meignin V, Mahr A, Tazi A.

Presse Med. 2017 Jan;46(1):55-69. doi: 10.1016/j.lpm.2016.09.015. Epub 2016 Nov 2. Review. French.

PMID:
27816338
33.

IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial.

Rini BI, Stenzl A, Zdrojowy R, Kogan M, Shkolnik M, Oudard S, Weikert S, Bracarda S, Crabb SJ, Bedke J, Ludwig J, Maurer D, Mendrzyk R, Wagner C, Mahr A, Fritsche J, Weinschenk T, Walter S, Kirner A, Singh-Jasuja H, Reinhardt C, Eisen T.

Lancet Oncol. 2016 Nov;17(11):1599-1611. doi: 10.1016/S1470-2045(16)30408-9. Epub 2016 Oct 3.

PMID:
27720136
34.

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C.

Ann Rheum Dis. 2016 Sep;75(9):1583-94. doi: 10.1136/annrheumdis-2016-209133. Epub 2016 Jun 23.

35.

Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population.

Pearce FA, Lanyon PC, Grainge MJ, Shaunak R, Mahr A, Hubbard RB, Watts RA.

Rheumatology (Oxford). 2016 Sep;55(9):1656-63. doi: 10.1093/rheumatology/kew232. Epub 2016 Jun 5.

PMID:
27274096
36.

The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015.

Miller M, Jahndel V, Kutscher S, Mahr A, Rae R, Kloke BP.

Cancer Immunol Immunother. 2016 Oct;65(10):1277-87. doi: 10.1007/s00262-016-1850-5. Epub 2016 Jun 3. No abstract available.

PMID:
27259506
37.

Do vaccinations affect the clinical course of systemic necrotising vasculitis? A prospective observational web-based study.

Kernéis S, Turbelin C, Pagnoux C, Launay O, Mahr AD, Guillevin L, Boëlle PY, Hanslik T.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S89-92. Epub 2016 May 19.

PMID:
27214210
38.

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life.

Pugnet G, Pagnoux C, Terrier B, Perrodeau E, Puéchal X, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S54-9. Epub 2016 Mar 25.

PMID:
27049404
39.

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).

Bienvenu B, Ly KH, Lambert M, Agard C, André M, Benhamou Y, Bonnotte B, de Boysson H, Espitia O, Fau G, Fauchais AL, Galateau-Sallé F, Haroche J, Héron E, Lapébie FX, Liozon E, Luong Nguyen LB, Magnant J, Manrique A, Matt M, de Menthon M, Mouthon L, Puéchal X, Pugnet G, Quemeneur T, Régent A, Saadoun D, Samson M, Sène D, Smets P, Yelnik C, Sailler L, Mahr A; Groupe d’Étude Français des Artérites des gros Vaisseaux, under the Aegis of the Filière des Maladies Auto-Immunes et Auto-Inflammatoires Rares.

Rev Med Interne. 2016 Mar;37(3):154-65. doi: 10.1016/j.revmed.2015.12.015. Epub 2016 Jan 29.

PMID:
26833145
40.

Kawasaki disease in adults: Observations in France and literature review.

Fraison JB, Sève P, Dauphin C, Mahr A, Gomard-Mennesson E, Varron L, Pugnet G, Landron C, Roblot P, Oziol E, Chalhoub G, Galempoix JM, Humbert S, Humbert P, Sbidian E, Grange F, Bayrou O, Cathebras P, Morlat P, Epaulard O, Pavese P, Huong du LT, Zoulim A, Stankovic K, Bachelez H, Smail A, Bachmeyer C, Granel B, Serratrice J, Brinchault G, Mekinian A, Costedoat-Chalumeau N, Bourgarit-Durand A, Puéchal X, Guillevin L, Piram M, Koné-Paut I, Fain O; CRI and the French Vasculitis Study Group.

Autoimmun Rev. 2016 Mar;15(3):242-9. doi: 10.1016/j.autrev.2015.11.010. Epub 2015 Nov 26. Review.

41.

'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease.

McGonagle D, Aydin SZ, Gül A, Mahr A, Direskeneli H.

Nat Rev Rheumatol. 2015 Dec;11(12):731-40. doi: 10.1038/nrrheum.2015.147. Epub 2015 Nov 3. Review.

PMID:
26526644
42.

Relationship between cutaneous polyarteritis nodosa (cPAN) and macular lymphocytic arteritis (MLA): Blinded histologic assessment of 35 cPAN cases.

Buffiere-Morgado A, Battistella M, Vignon-Pennamen MD, de Masson A, Rybojad M, Petit A, Cordoliani F, Begon E, Flageul B, Mahr A, Bagot M, Bouaziz JD.

J Am Acad Dermatol. 2015 Dec;73(6):1013-20. doi: 10.1016/j.jaad.2015.09.010. Epub 2015 Oct 20.

PMID:
26464220
43.

Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.

Hatemi G, Ozguler Y, Direskeneli H, Mahr A, Gul A, Levi V, Aydin SZ, Mumcu G, Sertel-Berk O, Stevens RM, Yazici H, Merkel PA.

J Rheumatol. 2015 Dec;42(12):2436-41. doi: 10.3899/jrheum.141147. Epub 2015 Sep 15. Review.

44.

Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.

Humbert S, Guilpain P, Puéchal X, Terrier B, Rivière S, Mahr A, Pagnoux C, Bagnères D, Cordier JF, Le Quellec A, Altwegg R, Guillevin L; French Vasculitis Study Group.

Rheumatology (Oxford). 2015 Nov;54(11):1970-5. doi: 10.1093/rheumatology/kev199. Epub 2015 Jun 22.

PMID:
26106214
45.

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

Aydin SZ, Direskeneli H, Sreih A, Alibaz-Oner F, Gul A, Kamali S, Hatemi G, Kermani T, Mackie SL, Mahr A, Meara A, Milman N, Nugent H, Robson J, Tomasson G, Merkel PA.

J Rheumatol. 2015 Dec;42(12):2465-9. doi: 10.3899/jrheum.141144. Epub 2015 Jun 15. Review.

46.

Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study.

Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Pichereau C, Brechot N, Duprey M, Mayaux J, Schenck M, Boisramé-Helms J, Thomas G, Baboi L, Mouthon L, Amoura Z, Papo T, Mahr A, Chevret S, Chiche JD, Azoulay E.

Chest. 2015 Oct;148(4):927-935. doi: 10.1378/chest.14-3098.

PMID:
25996557
47.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L.

Eur J Intern Med. 2015 Sep;26(7):545-53. doi: 10.1016/j.ejim.2015.04.022. Epub 2015 May 9.

48.

The tolerogenic function of annexins on apoptotic cells is mediated by the annexin core domain.

Linke B, Abeler-Dörner L, Jahndel V, Kurz A, Mahr A, Pfrang S, Linke L, Krammer PH, Weyd H.

J Immunol. 2015 Jun 1;194(11):5233-42. doi: 10.4049/jimmunol.1401299. Epub 2015 Apr 27.

49.

Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suárez LF.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i14-22. doi: 10.1093/ndt/gfv022. Review.

PMID:
25805746
50.

Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.

Pagnoux C, Quéméneur T, Ninet J, Diot E, Kyndt X, de Wazières B, Reny JL, Puéchal X, le Berruyer PY, Lidove O, Vanhille P, Godmer P, Fain O, Blockmans D, Bienvenu B, Rollot F, Aït el Ghaz-Poignant S, Mahr A, Cohen P, Mouthon L, Perrodeau E, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2015 Apr;67(4):1117-27. doi: 10.1002/art.39011.

Supplemental Content

Support Center